Sacituzumab Govitecan 180 mg Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 180 mg
Reference Brands: Trodelvy (USA/EU)
Category: Oncology Cancer Care
Sacituzumab Govitecan is a Oncology Cancer Care product available as Injection in strengths 180 mg. It corresponds to the reference brand Trodelvy (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Sacituzumab govitecan is a targeted anticancer medicine used for the treatment of certain advanced or metastatic cancers. It is an antibody–drug conjugate designed to deliver chemotherapy directly to cancer cells. The drug consists of a monoclonal antibody that targets the Trop-2 protein, which is commonly found on the surface of many tumor cells, combined with a topoisomerase inhibitor that helps destroy cancer cells. By binding to Trop-2 and releasing the cytotoxic agent inside the tumor, sacituzumab govitecan helps reduce tumor growth while focusing treatment on cancer cells.
This therapy is used in patients with metastatic triple-negative breast cancer who have previously received other treatments. It is also approved for patients with metastatic hormone receptor-positive, HER2-negative breast cancer that has progressed after prior therapies. In addition, sacituzumab govitecan is used in certain cases of metastatic urothelial cancer when other treatment options have been used.
Because of its targeted delivery system, sacituzumab govitecan represents an important advancement in modern oncology treatments. It provides an additional option for patients with difficult-to-treat cancers and helps improve disease management in advanced stages of these conditions.
Sacituzumab Govitecan — third party manufacturing & bulk supply
Sacituzumab Govitecan 180 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Sacituzumab Govitecan is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Sacituzumab Govitecan listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Sacituzumab Govitecan →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Sacituzumab govitecan-hziy is used for the treatment of certain advanced or metastatic cancers, particularly triple-negative breast cancer (TNBC) and some cases of hormone receptor-positive, HER2-negative breast cancer that have progressed after prior therapies. It is also used in certain cases of advanced urothelial (bladder) cancer.
Sacituzumab govitecan-hziy is an antibody–drug conjugate that combines a monoclonal antibody targeting the Trop-2 protein with a cytotoxic chemotherapy agent. This design allows the drug to deliver chemotherapy directly to cancer cells that express the Trop-2 antigen.
The primary trade name of Sacituzumab govitecan-hziy is Trodelvy.
Sacituzumab govitecan-hziy (Trodelvy) is developed and marketed by Gilead Sciences.
The generic name is Sacituzumab govitecan-hziy.
The main brand name is Trodelvy.
Sacituzumab govitecan-hziy is manufactured in GMP-certified biologics production facilities approved by major regulatory authorities such as the US FDA, EMA, and other international health agencies depending on the market where it is supplied.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
